factors for modulation of age at fees from healthcare manufacture germany and biogen. j. faber is reonset in machado - joseph disease / spinocerebellar ataxia type 3 : ceiving research support from the bundesministerium fur bildung und a systematic review and meta - analysis. j neurol neurosurg psyforschung ( bmbf ), the national ataxia foundation ( naf ), servier, chiatry. 2019 ; 90 : 203 – 10. and ucb. within the last 24 months, she has received consulting fees 14. van prooije th, kapteijns kcj, van asten jja, inthout j, verfrom vico therapeutics. beek mm, scheenen twj, van de warrenburg bp, multimodal. longitudinal profiling of sca1 identifies predictors of disease open access this article is licensed under a creative commons severity and progression. ann neurol. 2024 ; 96 : 774 – 87. https : / / d attribution4. 0internationallicense, which permits use, sharing, o i. o r g / 1 0. 1 0 0 2 / a n a. 2 7 0 3 2. adaptation, distribution and reproduction in any medium or format, 15. jacobi h, du montcel st, bauer p, giunti p, cook a, labrum as long as you give appropriate credit to the original author ( s ) and the r, et al. long - term disease progression in spinocerebellar ataxia source, provide a link to the creative commons licence, and indicate types 1, 2, 3, and 6 : a longitudinal cohort study. lancet neurol. if changes were made. the images or other third party material in this 2015 ; 14 : 1101 – 8. article are included in the article ’ s creative commons licence, unless 16. klockgether t, ludtke r, kramer b, abele m, burk k, schols l, indicated otherwise in a credit line to the material. if material is not et al. the natural history of degenerative ataxia : a retrospective included in the article ’ s creative commons licence and your intended study in 466 patients. brain. 1998 ; 121 : 589 – 600. use is not permitted by statutory regulation or exceeds the permitted 17. jardim lb, ha